• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人补体C4及其基因变体C4A3和C4B1与免疫球蛋白的液相结合。

The fluid-phase binding of human C4 and its genetic variants, C4A3 and C4B1, to immunoglobulins.

作者信息

Kishore N, Shah D, Skanes V M, Levine R P

机构信息

James S. McDonnell Department of Genetics, Washington University School of Medicine, St. Louis, MO 63110.

出版信息

Mol Immunol. 1988 Sep;25(9):811-9. doi: 10.1016/0161-5890(88)90117-4.

DOI:10.1016/0161-5890(88)90117-4
PMID:3264881
Abstract

Covalent binding of the fourth complement protein, C4, to immune complexes is an important first step in the complement mediated processing of the complexes. Many of the initial encounters between the proteins of the complement system and antigen and antibody occur in solution, and prior to this report, studies of the interactions between them have focused on complement binding to preformed immune precipitates that most likely are not found in vivo. We have characterized the covalent binding of C4b to immunoglobulin molecules in a fluid-phase system consisting only of antibody in solution and purified C4 and C1s. We demonstrate that human C4b binds to IgG in the fluid phase, that its covalent binding is predominantly to the heavy chain of IgG, and that the covalent linkage is by either amide or acyl ester bonds. In addition, we compare the covalent binding efficiencies of two genetic variants of C4, C4A3 and C4B1, to IgG. C4A3 binds 3-4 times more IgG than C4B1 over a range of C4 concentrations, and C4A3 has a higher binding efficiency than C4B1 for IgM, IgA, IgG2a and F(ab')2 as well as for a protein antigen, BSA. Furthermore, we found that whereas C4A3 is bound to immunoglobulins in the fluid-phase predominantly by amide linkage, C4B1 is bound by either amide or acyl ester bonds. The results presented here suggest that the covalent binding efficiency of C4A3 and C4B1 to IgG is similar to that reported for their covalent binding to small molecules.

摘要

补体系统的第四种补体蛋白C4与免疫复合物的共价结合是补体介导处理这些复合物的重要第一步。补体系统的蛋白质与抗原和抗体之间的许多初始相互作用发生在溶液中,在本报告之前,对它们之间相互作用的研究集中在补体与预先形成的免疫沉淀物的结合上,而这些沉淀物很可能在体内并不存在。我们在一个仅由溶液中的抗体以及纯化的C4和C1s组成的液相系统中,对C4b与免疫球蛋白分子的共价结合进行了表征。我们证明人类C4b在液相中与IgG结合,其共价结合主要发生在IgG的重链上,并且共价连接是通过酰胺键或酰基酯键。此外,我们比较了C4的两种基因变体C4A3和C4B1与IgG的共价结合效率。在一系列C4浓度范围内,C4A3结合的IgG比C4B1多3 - 4倍,并且C4A3对IgM、IgA、IgG2a和F(ab')2以及蛋白质抗原牛血清白蛋白(BSA)的结合效率高于C4B1。此外,我们发现虽然C4A3在液相中与免疫球蛋白的结合主要通过酰胺键,而C4B1则通过酰胺键或酰基酯键结合。此处呈现的结果表明,C4A3和C4B1与IgG的共价结合效率与它们与小分子的共价结合效率相似。

相似文献

1
The fluid-phase binding of human C4 and its genetic variants, C4A3 and C4B1, to immunoglobulins.人补体C4及其基因变体C4A3和C4B1与免疫球蛋白的液相结合。
Mol Immunol. 1988 Sep;25(9):811-9. doi: 10.1016/0161-5890(88)90117-4.
2
C4-mediated inhibition of immune precipitation and differences in inhibitory action of genetic variants, C4A3 and C4B1.C4介导的免疫沉淀抑制作用以及基因变体C4A3和C4B1抑制作用的差异
Complement. 1988;5(3):110-9. doi: 10.1159/000463045.
3
Functional properties of heterogeneous human asialo-C4 and its isotypes C4A and C4B.人源异质性脱唾液酸C4及其同种型C4A和C4B的功能特性
Immunobiology. 1992 Jun;185(1):90-102. doi: 10.1016/S0171-2985(11)80320-7.
4
The binding of human complement component C4 to antibody-antigen aggregates.人补体成分C4与抗体-抗原聚集体的结合。
Biochem J. 1980 Jul 1;189(1):67-80. doi: 10.1042/bj1890067.
5
Binding to erythrocyte complement receptor type 1 of BSA/anti-BSA complexes opsonized by C4A3 or C4B1 in the presence of serum.在血清存在的情况下,C4A3或C4B1调理的牛血清白蛋白/抗牛血清白蛋白复合物与红细胞补体受体1的结合。
Scand J Immunol. 1995 Oct;42(4):425-32. doi: 10.1111/j.1365-3083.1995.tb03676.x.
6
The low C5 convertase activity of the C4A6 allotype of human complement component C4.人类补体成分C4的C4A6同种异型的低C5转化酶活性。
Biochem J. 1989 Aug 1;261(3):743-8. doi: 10.1042/bj2610743.
7
Differences in the metabolism of C4 isotypes in patients with complement activation.补体激活患者中C4同种型代谢的差异。
Clin Exp Immunol. 1989 Oct;78(1):49-53.
8
Amino acid residues 1101-1105 of the isotypic region of human C4B is important to the covalent binding activity of complement component C4.人C4B同种型区域的氨基酸残基1101 - 1105对补体成分C4的共价结合活性很重要。
J Immunol. 1991 Nov 1;147(9):3018-23.
9
Formation of covalent complexes between the fourth component of human complement and IgG immune aggregates.人补体第四成分与IgG免疫聚集体之间共价复合物的形成。
Complement. 1987;4(1):21-32. doi: 10.1159/000463004.
10
A study of a covalent-like interaction between soluble nascent C4b and C4-binding protein.可溶性新生C4b与C4结合蛋白之间类共价相互作用的研究。
Biochim Biophys Acta. 1982 Jun 4;704(2):197-203. doi: 10.1016/0167-4838(82)90146-7.

引用本文的文献

1
Defective prevention of immune precipitation in autoimmune diseases is independent of C4A*Q0.自身免疫性疾病中免疫沉淀预防缺陷与C4A*Q0无关。
Clin Exp Immunol. 2005 Jun;140(3):572-9. doi: 10.1111/j.1365-2249.2005.02794.x.
2
A CR1 polymorphism associated with constitutive erythrocyte CR1 levels affects binding to C4b but not C3b.一种与组成性红细胞CR1水平相关的CR1多态性影响与C4b的结合,但不影响与C3b的结合。
Immunology. 2003 Apr;108(4):531-8. doi: 10.1046/j.1365-2567.2003.01579.x.
3
Mechanism of complement-dependent haemolysis via the lectin pathway: role of the complement regulatory proteins.
通过凝集素途径的补体依赖性溶血机制:补体调节蛋白的作用
Clin Exp Immunol. 1999 Sep;117(3):442-8. doi: 10.1046/j.1365-2249.1999.00998.x.
4
Analysis of human C4A and C4B binding to an immune complex in serum.人C4A和C4B与血清中免疫复合物结合情况的分析。
Clin Exp Immunol. 1999 Jul;117(1):12-8. doi: 10.1046/j.1365-2249.1999.00940.x.
5
Quantitative analysis of C4Ab and C4Bb binding to the C3b/C4b receptor (CR1, CD35).C4Ab和C4Bb与C3b/C4b受体(CR1,CD35)结合的定量分析。
Clin Exp Immunol. 1997 Nov;110(2):310-6. doi: 10.1111/j.1365-2249.1997.tb08333.x.
6
Complement deficiency and immune complex disease.补体缺陷与免疫复合物疾病
Springer Semin Immunopathol. 1994;15(4):397-416. doi: 10.1007/BF01837367.
7
Substitution of a single amino acid (aspartic acid for histidine) converts the functional activity of human complement C4B to C4A.单个氨基酸的替换(组氨酸替换为天冬氨酸)可将人补体C4B的功能活性转变为C4A的功能活性。
Proc Natl Acad Sci U S A. 1990 Sep;87(17):6868-72. doi: 10.1073/pnas.87.17.6868.
8
Differences between C4A and C4B in the handling of immune complexes: the enhancement of CR1 binding is more important than the inhibition of immunoprecipitation.C4A与C4B在处理免疫复合物方面的差异:补体受体1(CR1)结合的增强比免疫沉淀的抑制更重要。
Clin Exp Immunol. 1990 Feb;79(2):158-63. doi: 10.1111/j.1365-2249.1990.tb05172.x.
9
A unique recombination event resulting in a C4A*Q0,C4B*Q0 double null haplotype.一个独特的重组事件,导致C4A*Q0、C4B*Q0双无效单倍型。
J Clin Invest. 1992 Oct;90(4):1180-4. doi: 10.1172/JCI115978.
10
The relative roles of C4A and C4B in prevention of immune precipitation, solubilisation and immune adherence.
Rheumatol Int. 1992;12(5):187-90. doi: 10.1007/BF00302150.